Clemente Garcia-Rizo
Clemente Garcia-Rizo
Barcelona Clinic Schizophrenia Unit. CIBERSAM. IDIBAPS.
No verified email - Homepage
Cited by
Cited by
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
E Fernandez-Egea, M Bernardo, T Donner, I Conget, E Parellada, ...
The British journal of psychiatry 194 (5), 434-438, 2009
Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study
R Penadés, N Pujol, R Catalán, G Massana, G Rametti, C García-Rizo, ...
Biological psychiatry 73 (10), 1015-1023, 2013
Glucose abnormalities in the siblings of people with schizophrenia
E Fernandez-Egea, M Bernardo, E Parellada, A Justicia, C Garcia-Rizo, ...
Schizophrenia research 103 (1-3), 110-113, 2008
Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?
B Kirkpatrick, BJ Miller, C Garcia-Rizo, E Fernandez-Egea, M Bernardo
Schizophrenia bulletin 38 (2), 280-284, 2012
Prolactin concentrations in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis
C Garcia-Rizo, E Fernandez-Egea, C Oliveira, A Justicia, E Parellada, ...
Schizophrenia research 134 (1), 16-19, 2012
Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naive patients with depression
C Garcia-Rizo, E Fernandez-Egea, BJ Miller, C Oliveira, A Justicia, ...
Brain, behavior, and immunity 28, 49-53, 2013
Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features
C Garcia-Rizo, E Fernandez-Egea, C Oliveira, A Justicia, M Bernardo, ...
Psychiatry research 198 (2), 212-215, 2012
Differences in glucose tolerance between deficit and nondeficit schizophrenia
B Kirkpatrick, E Fernandez-Egea, C Garcia-Rizo, M Bernardo
Schizophrenia research 107 (2-3), 122-127, 2009
Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis
AM Greenhalgh, L Gonzalez-Blanco, C Garcia-Rizo, E Fernandez-Egea, ...
Schizophrenia research 179, 57-63, 2017
Prolactin concentrations in antipsychotic-naive patients with schizophrenia and related disorders: a meta-analysis
L González-Blanco, AMD Greenhalgh, C Garcia-Rizo, E Fernandez-Egea, ...
Schizophrenia research 174 (1-3), 156-160, 2016
Metabolic effects of olanzapine in patients with newly diagnosed psychosis
E Fernandez-Egea, B Miller, MB Clemente Garcia-Rizo, B Kirkpatrick
Journal of clinical psychopharmacology 31 (2), 154, 2011
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics
ÁL Montejo, C Arango, M Bernardo, JL Carrasco, B Crespo-Facorro, ...
Frontiers in neuroendocrinology 45, 25-34, 2017
Spanish adaptation and validation of the Brief Negative Symptoms Scale
A Mané, C García-Rizo, MP Garcia-Portilla, D Bergé, G Sugranyes, ...
Comprehensive psychiatry 55 (7), 1726-1729, 2014
Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis
E Fernandez-Egea, C García-Rizo, B Miller, E Parellada, A Justicia, ...
Psychosomatic medicine 73 (8), 643, 2011
Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia
ÁL Montejo, C Arango, M Bernardo, JL Carrasco, B Crespo-Facorro, ...
Revista de Psiquiatría y Salud Mental (English Edition) 9 (3), 158-173, 2016
Schizophrenia: a systemic disorder
B Kirkpatrick, B Miller, C García-Rizo, E Fernandez-Egea
Clinical schizophrenia & related psychoses 8 (2), 73-79, 2014
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative …
V Soria, A González-Rodríguez, E Huerta-Ramos, J Usall, J Cobo, ...
Psychoneuroendocrinology 93, 8-19, 2018
Abnormal glycemic homeostasis at the onset of serious mental illnesses: a common pathway
C Garcia-Rizo, B Kirkpatrick, E Fernandez-Egea, C Oliveira, M Bernardo
Psychoneuroendocrinology 67, 70-75, 2016
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis
M Bioque, MP García-Portilla, C García-Rizo, B Cabrera, A Lobo, ...
Schizophrenia research 193, 188-196, 2018
Screening for substance use disorders in first-episode psychosis: Implications for readmission
A Batalla, C Garcia-Rizo, P Castellví, E Fernandez-Egea, M Yücel, ...
Schizophrenia research 146 (1-3), 125-131, 2013
The system can't perform the operation now. Try again later.
Articles 1–20